Skip to main content
Top
Published in: Current Geriatrics Reports 3/2013

01-09-2013 | Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Issues Surrounding Antibiotic Use in Older Adults

Authors: Caitlin Biedron, Teena Chopra

Published in: Current Geriatrics Reports | Issue 3/2013

Login to get access

Abstract

By the year 2030, an estimated 20 % of the United States population will be aged 65 years and older, and almost 30 million of these individuals are anticipated to have functional limitations necessitating long-term care. Older adults’ increased susceptibility to nosocomial infections, combined with their often atypical presentation, results in a tendency to inappropriately prescribe antibiotics in long-term care facilities (LTCFs). Furthermore, reduced laboratory capacity in LTCFs can cause significant delays in receiving culture results and prolonged duration of empiric antimicrobial therapy. This review explores these factors and other issues contributing to the misuse and overuse of antibiotics as they relate to diagnosis, transmission, and management of infections in older adults. Inappropriate antimicrobial use has considerable consequences, including the development of multidrug resistant organisms, increasing incidence and mortality related to Clostridium difficile infection, and increasing adverse drug reactions, and therefore prompt and coordinated action is required to address this growing public health threat.
Literature
1.
go back to reference • Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52 Suppl 5:S397–428. This policy paper summarizes the Infectious Disease Society of America's (IDSA) recommendations in terms of addressing the simultaneous crises of rising rates of antibiotic resistance and waning approvals of new antibiotics. IDSA puts forth public policy strategies and research activities that have the potential to preserve the effectiveness of antibiotics and reverse the concerning decline in the antibiotic R&D pipeline.PubMed • Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52 Suppl 5:S397–428. This policy paper summarizes the Infectious Disease Society of America's (IDSA) recommendations in terms of addressing the simultaneous crises of rising rates of antibiotic resistance and waning approvals of new antibiotics. IDSA puts forth public policy strategies and research activities that have the potential to preserve the effectiveness of antibiotics and reverse the concerning decline in the antibiotic R&D pipeline.PubMed
2.
go back to reference Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–12.PubMedCrossRef Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–12.PubMedCrossRef
3.
go back to reference Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control. 2008;36(7):504–35.PubMedCrossRef Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control. 2008;36(7):504–35.PubMedCrossRef
4.
go back to reference Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008;46(4):497–504.PubMedCrossRef Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008;46(4):497–504.PubMedCrossRef
5.
go back to reference •• Flanagan E, Chopra T, Mody L. Infection prevention in alternative health care settings. Infect Dis Clin N Am. 2011;25(1):271–83. This article outlines the key elements of an infection control program in a skilled nursing facility, which should include surveillance for infections and antimicrobial resistance, an outbreak investigation and control plan for epidemics, isolation precautions, and hand hygiene. It also highlights the unique aspects of LTCF residents which make infection control efforts more challenging, including their need for rehabilitation and physical therapy services and their frequent involvement in transitions of care.CrossRef •• Flanagan E, Chopra T, Mody L. Infection prevention in alternative health care settings. Infect Dis Clin N Am. 2011;25(1):271–83. This article outlines the key elements of an infection control program in a skilled nursing facility, which should include surveillance for infections and antimicrobial resistance, an outbreak investigation and control plan for epidemics, isolation precautions, and hand hygiene. It also highlights the unique aspects of LTCF residents which make infection control efforts more challenging, including their need for rehabilitation and physical therapy services and their frequent involvement in transitions of care.CrossRef
6.
go back to reference High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(2):149–71.PubMedCrossRef High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(2):149–71.PubMedCrossRef
7.
go back to reference •• Smith PW, Watkins K, Miller H, et al. Antibiotic stewardship programs in long-term care facilities. Ann Long-Term Care Clin Care Aging. 2011;19(4):20–5. This article provides an overview of antibiotic use and resistance in long-term care facilities, and discusses how various components of antibiotic stewardship programs can be applied to the long-term care setting. Furthermore, a step-wise approach to implementation of an ASP is recommended, starting with the least costly and intrusive steps, and gradually working towards introducing an antimicrobial appropriateness review process, which requires expert review of individual cases. •• Smith PW, Watkins K, Miller H, et al. Antibiotic stewardship programs in long-term care facilities. Ann Long-Term Care Clin Care Aging. 2011;19(4):20–5. This article provides an overview of antibiotic use and resistance in long-term care facilities, and discusses how various components of antibiotic stewardship programs can be applied to the long-term care setting. Furthermore, a step-wise approach to implementation of an ASP is recommended, starting with the least costly and intrusive steps, and gradually working towards introducing an antimicrobial appropriateness review process, which requires expert review of individual cases.
8.
go back to reference Levenson S. Fever and leukocytosis. Caring Ages. 2003;4(7):15–47. Levenson S. Fever and leukocytosis. Caring Ages. 2003;4(7):15–47.
9.
11.
go back to reference Gross PA, Patel B. Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis. 2007;45(10):1335–7.PubMedCrossRef Gross PA, Patel B. Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis. 2007;45(10):1335–7.PubMedCrossRef
12.
go back to reference Loeb M, Brazil K, Lohfeld L, McGeer A, Simor A, Stevenson K, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ. 2005;331(7518):669.PubMedCrossRef Loeb M, Brazil K, Lohfeld L, McGeer A, Simor A, Stevenson K, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ. 2005;331(7518):669.PubMedCrossRef
13.
go back to reference Friedman C, Barnette M, Buck AS, Ham R, Harris JA, Hoffman P, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol Consens Dev Conf. 1999;20(10):695–705.CrossRef Friedman C, Barnette M, Buck AS, Ham R, Harris JA, Hoffman P, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol Consens Dev Conf. 1999;20(10):695–705.CrossRef
14.
go back to reference Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ. Long-term acute care hospital utilization after critical illness. JAMA. 2010;303(22):2253–9.PubMedCrossRef Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ. Long-term acute care hospital utilization after critical illness. JAMA. 2010;303(22):2253–9.PubMedCrossRef
15.
go back to reference Daneman N, Gruneir A, Newman A, Fischer HD, Bronskill SE, Rochon PA, et al. Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011;66(12):2856–63.PubMedCrossRef Daneman N, Gruneir A, Newman A, Fischer HD, Bronskill SE, Rochon PA, et al. Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011;66(12):2856–63.PubMedCrossRef
16.
go back to reference Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EG, Smith PW. Antimicrobial use in long-term-care facilities. SHEA long-term-care committee. Infect Control Hosp Epidemiol. 2000;21(8):537–45.PubMedCrossRef Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EG, Smith PW. Antimicrobial use in long-term-care facilities. SHEA long-term-care committee. Infect Control Hosp Epidemiol. 2000;21(8):537–45.PubMedCrossRef
17.
go back to reference Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc. 1991;39(10):963–72.PubMed Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc. 1991;39(10):963–72.PubMed
18.
go back to reference Zimmer JG, Bentley DW, Valenti WM, Watson NM. Systemic antibiotic use in nursing homes. A quality assessment. J Am Geriatr Soc. 1986;34(10):703–10.PubMed Zimmer JG, Bentley DW, Valenti WM, Watson NM. Systemic antibiotic use in nursing homes. A quality assessment. J Am Geriatr Soc. 1986;34(10):703–10.PubMed
19.
go back to reference Mylotte JM. Measuring antibiotic use in a long-term care facility. Am J Infect Control. 1996;24(3):174–9.PubMedCrossRef Mylotte JM. Measuring antibiotic use in a long-term care facility. Am J Infect Control. 1996;24(3):174–9.PubMedCrossRef
20.
go back to reference Lee YL, Thrupp LD, Friis RH, Fine M, Maleki P, Cesario TC. Nosocomial infection and antibiotic utilization in geriatric patients: a pilot prospective surveillance program in skilled nursing facilities. Gerontology. 1992;38(4):223–32.PubMedCrossRef Lee YL, Thrupp LD, Friis RH, Fine M, Maleki P, Cesario TC. Nosocomial infection and antibiotic utilization in geriatric patients: a pilot prospective surveillance program in skilled nursing facilities. Gerontology. 1992;38(4):223–32.PubMedCrossRef
21.
go back to reference Loeb M, Simor AE, Landry L, Walter S, McArthur M, Duffy J, et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med. 2001;16(6):376–83.PubMedCrossRef Loeb M, Simor AE, Landry L, Walter S, McArthur M, Duffy J, et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med. 2001;16(6):376–83.PubMedCrossRef
22.
go back to reference • Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157–62. This report demonstrates that of all health-care–associated CDIs, 75 % have their onset outside of hospitals, and argues that major reductions will therefore require antibiotic stewardship along with infection control applied to long-term care and ambulatory-care settings as well as hospitals. It also advocates for the extension of State health department programs to cover healthcare settings beyond hospitals, where they have already demonstrated success in preventing CDIs. • Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157–62. This report demonstrates that of all health-care–associated CDIs, 75 % have their onset outside of hospitals, and argues that major reductions will therefore require antibiotic stewardship along with infection control applied to long-term care and ambulatory-care settings as well as hospitals. It also advocates for the extension of State health department programs to cover healthcare settings beyond hospitals, where they have already demonstrated success in preventing CDIs.
23.
go back to reference Crnich CJ, Safdar N, Robinson J, Zimmerman D. Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004. Infect Control Hosp Epidemiol. 2007;28(8):1006–8.PubMedCrossRef Crnich CJ, Safdar N, Robinson J, Zimmerman D. Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004. Infect Control Hosp Epidemiol. 2007;28(8):1006–8.PubMedCrossRef
24.
go back to reference Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93.PubMedCrossRef Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93.PubMedCrossRef
25.
go back to reference Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164.PubMedCrossRef Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164.PubMedCrossRef
26.
go back to reference O'Fallon E, Harper J, Shaw S, Lynfield R. Antibiotic and infection tracking in Minnesota long-term care facilities. J Am Geriatr Soc. 2007;55(8):1243–7.PubMedCrossRef O'Fallon E, Harper J, Shaw S, Lynfield R. Antibiotic and infection tracking in Minnesota long-term care facilities. J Am Geriatr Soc. 2007;55(8):1243–7.PubMedCrossRef
27.
go back to reference Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis. 2010;50(12):1611–6.PubMedCrossRef Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis. 2010;50(12):1611–6.PubMedCrossRef
28.
go back to reference Bonomo RA. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis. 2000;31(6):1414–22.PubMedCrossRef Bonomo RA. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis. 2000;31(6):1414–22.PubMedCrossRef
29.
go back to reference O'Fallon E, Schreiber R, Kandel R, D'Agata EM. Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol. 2009;30(12):1172–9.PubMedCrossRef O'Fallon E, Schreiber R, Kandel R, D'Agata EM. Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol. 2009;30(12):1172–9.PubMedCrossRef
30.
go back to reference Suetens C, Niclaes L, Jans B, Verhaegen J, Schuermans A, Van Eldere J, et al. Methicillin-resistant Staphylococcus aureus colonization is associated with higher mortality in nursing home residents with impaired cognitive status. J Am Geriatr Soc. 2006;54(12):1854–60.PubMedCrossRef Suetens C, Niclaes L, Jans B, Verhaegen J, Schuermans A, Van Eldere J, et al. Methicillin-resistant Staphylococcus aureus colonization is associated with higher mortality in nursing home residents with impaired cognitive status. J Am Geriatr Soc. 2006;54(12):1854–60.PubMedCrossRef
31.
go back to reference Capitano B, Nicolau DP. Evolving epidemiology and cost of resistance to antimicrobial agents in long-term care facilities. J Am Med Dir Assoc. 2003;4(3 Suppl):S90–9.PubMedCrossRef Capitano B, Nicolau DP. Evolving epidemiology and cost of resistance to antimicrobial agents in long-term care facilities. J Am Med Dir Assoc. 2003;4(3 Suppl):S90–9.PubMedCrossRef
32.
go back to reference Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol. 1992;13(12):725–37.PubMedCrossRef Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol. 1992;13(12):725–37.PubMedCrossRef
33.
go back to reference Wendt C, Svoboda D, Schmidt C, Bock-Hensley O, von Baum H. Characteristics that promote transmission of Staphylococcus aureus nursing homes in German nursing homes. Infect Control Hosp Epidemiol. 2005;26(10):816–21.PubMedCrossRef Wendt C, Svoboda D, Schmidt C, Bock-Hensley O, von Baum H. Characteristics that promote transmission of Staphylococcus aureus nursing homes in German nursing homes. Infect Control Hosp Epidemiol. 2005;26(10):816–21.PubMedCrossRef
34.
go back to reference Flournoy DJ. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology. 1994;40(1):53–6.PubMedCrossRef Flournoy DJ. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology. 1994;40(1):53–6.PubMedCrossRef
35.
go back to reference Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA technical panel on infections within hospitals. Infect Control Hosp Epidemiol. 1994;15(2):105–15.PubMedCrossRef Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA technical panel on infections within hospitals. Infect Control Hosp Epidemiol. 1994;15(2):105–15.PubMedCrossRef
36.
go back to reference ArftN S. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470–85.CrossRef ArftN S. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470–85.CrossRef
37.
go back to reference Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 2007;29(6):630–6.PubMedCrossRef Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 2007;29(6):630–6.PubMedCrossRef
38.
go back to reference Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, et al. Carbapenem-resistant escherichia coli harboring klebsiella pneumoniae carbapenemase β-lactamases associated with long-term care facilities. Clin Infect Dis. 2008;46(11):e127–30.PubMedCrossRef Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, et al. Carbapenem-resistant escherichia coli harboring klebsiella pneumoniae carbapenemase β-lactamases associated with long-term care facilities. Clin Infect Dis. 2008;46(11):e127–30.PubMedCrossRef
39.
go back to reference Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of Polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–41.PubMedCrossRef Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of Polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–41.PubMedCrossRef
40.
go back to reference Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.PubMedCrossRef Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.PubMedCrossRef
41.
go back to reference •• Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, et al. Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc. 2013;61(2):222–30. This article demonstrates that risk factors accounting for poorer outcomes of Clostridium difficile treatment with advancing age include infection with the B1 strain type, inpatient status, renal insufficiency, leukocytosis, hypoalbuminemia, and concomitant medication exposure. It also argues that the measurable deterioration in treatment outcomes that occurred with advancing age underscores the need for more effective prevention and treatment strategies.PubMedCrossRef •• Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, et al. Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc. 2013;61(2):222–30. This article demonstrates that risk factors accounting for poorer outcomes of Clostridium difficile treatment with advancing age include infection with the B1 strain type, inpatient status, renal insufficiency, leukocytosis, hypoalbuminemia, and concomitant medication exposure. It also argues that the measurable deterioration in treatment outcomes that occurred with advancing age underscores the need for more effective prevention and treatment strategies.PubMedCrossRef
42.
go back to reference Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009;301(9):954–62.PubMedCrossRef Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009;301(9):954–62.PubMedCrossRef
43.
go back to reference Kelly CP, LaMont JT. Clostridium difficile–more difficult than ever. N Engl J Med. 2008;359(18):1932–40.PubMedCrossRef Kelly CP, LaMont JT. Clostridium difficile–more difficult than ever. N Engl J Med. 2008;359(18):1932–40.PubMedCrossRef
44.
go back to reference Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(2):222–7.CrossRef Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(2):222–7.CrossRef
45.
go back to reference Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–9.PubMedCrossRef Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–9.PubMedCrossRef
46.
go back to reference Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical Infect Dis Off Publ Infect Dis Soc Am. 2005;40(11):1591–7.CrossRef Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical Infect Dis Off Publ Infect Dis Soc Am. 2005;40(11):1591–7.CrossRef
47.
go back to reference Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis. 2012;55(2):216–23.PubMedCrossRef Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis. 2012;55(2):216–23.PubMedCrossRef
48.
go back to reference Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50(2):194–201.PubMedCrossRef Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50(2):194–201.PubMedCrossRef
49.
go back to reference Laffan AM, Bellantoni MF, Greenough 3rd WB, Zenilman JM. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc. 2006;54(7):1068–73.PubMedCrossRef Laffan AM, Bellantoni MF, Greenough 3rd WB, Zenilman JM. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc. 2006;54(7):1068–73.PubMedCrossRef
50.
go back to reference Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–43.PubMedCrossRef Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–43.PubMedCrossRef
51.
go back to reference Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121–6.PubMedCrossRef Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121–6.PubMedCrossRef
52.
go back to reference Owens RC, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41(Supplement 2):S144–57.PubMedCrossRef Owens RC, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41(Supplement 2):S144–57.PubMedCrossRef
53.
go back to reference Richards Jr CL, Darradji M, Weinberg A, Ouslander JG. Antimicrobial use in post-acute care: a retrospective descriptive analysis in seven long-term care facilities in Georgia. J Am Med Dir Assoc. 2005;6(2):109–12.PubMedCrossRef Richards Jr CL, Darradji M, Weinberg A, Ouslander JG. Antimicrobial use in post-acute care: a retrospective descriptive analysis in seven long-term care facilities in Georgia. J Am Med Dir Assoc. 2005;6(2):109–12.PubMedCrossRef
Metadata
Title
Issues Surrounding Antibiotic Use in Older Adults
Authors
Caitlin Biedron
Teena Chopra
Publication date
01-09-2013
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 3/2013
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-013-0050-9

Other articles of this Issue 3/2013

Current Geriatrics Reports 3/2013 Go to the issue

Neurology of Aging (KS Marder, Section Editor)

Relationship of Gait and Cognition in the Elderly

Neurology of Aging (KS Marder, Section Editor)

Update on Dementia with Lewy Bodies

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Impact and Management of MRSA in the Long-Term Care Setting

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Issues in the Diagnosis and Management of Urinary Tract Infections in the Older Adult

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

The Epidemiology and Clinical Impact of Surgical Site Infections in the Older Adult

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.